MIMS is proud to announce the launch of MIMS Pulse, our new Clinical Decision Support (CDS) platform, unveiled at HIMSS Singapore 2026 (August 23-25).
As healthcare systems continue to accelerate their digital transformation, healthcare organisations are seeking solutions that combine trusted clinical knowledge with modern, connected technology. MIMS Pulse has been designed to meet this need by bringing together MIMS' trusted medicines information, built over more than 60 years, with a next-generation platform that supports safer, faster, and more efficient clinical workflows.
Key capabilities of MIMS Pulse include:-
Trusted Medicines Information
Evidence-based, peer-reviewed medicines information that healthcare professionals can rely on at the point of care. -
Seamless Integration
Modern APIs that enable flexible integration with electronic medical records, healthcare applications, and digital health ecosystems. -
Flexible Deployment
Available through cloud-based or on-premises deployment models to support diverse healthcare environments and organisational requirements. -
Future-Ready Interoperability
Built to support modern healthcare terminology, interoperability frameworks, and evolving digital health standards. -
Advanced Clinical Decision Support
Integrated alerts and checks covering drug interactions, allergies, pregnancy, lactation, and other critical medication safety considerations.
MIMS CEO Sohil Goswami said this about the launch:
"I would like to congratulate the CDS team and everyone across MIMS who has contributed to bringing MIMS Pulse to market. Launching at HIMSS Singapore is an important milestone and a great opportunity to showcase what MIMS is building for the future of healthcare: Safer Medications, Better Care."
Download the flyer to know more about MIMS Pulse.